Buckingham Capital Management Inc. cut its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,642 shares of the financial services provider’s stock after selling 906 shares during the period. Buckingham Capital Management Inc.’s holdings in MetLife were worth $1,445,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after purchasing an additional 68,579 shares during the period. Nordea Investment Management AB raised its position in MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after buying an additional 608,224 shares during the last quarter. Swedbank AB raised its position in MetLife by 76.0% during the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after buying an additional 1,496,645 shares during the last quarter. Jennison Associates LLC lifted its stake in shares of MetLife by 3.6% in the 4th quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock worth $268,096,000 after acquiring an additional 114,166 shares during the period. Finally, Stifel Financial Corp boosted its holdings in shares of MetLife by 5.0% in the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after acquiring an additional 105,762 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on MET. Wells Fargo & Company reduced their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research report on Tuesday, January 14th. TD Cowen raised their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Barclays dropped their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Keefe, Bruyette & Woods reduced their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. Finally, BMO Capital Markets initiated coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 target price on the stock. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.17.
MetLife Price Performance
MetLife stock opened at $81.78 on Tuesday. The firm has a market capitalization of $56.63 billion, a PE ratio of 13.70, a P/E/G ratio of 0.64 and a beta of 1.07. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The firm’s 50-day simple moving average is $83.41 and its 200 day simple moving average is $81.11. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, equities research analysts predict that MetLife, Inc. will post 9.63 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- The Role Economic Reports Play in a Successful Investment Strategy
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- How to Evaluate a Stock Before Buying
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Conflicting Signals: Tempus AI’s Stock Market Rally
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.